Side-by-Side Comparison · 2026

5-Amino-1MQ vs CagriSema

5-Amino-1MQ vs CagriSema — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

5-Amino-1MQ
Metabolic & Mitochondrial

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates NAD+ metabolism and energy expenditure in adipose tissue. By blocking NNMT, 5-Amino-1MQ raises intracellular NAD+ and SAM levels, pushing stem cells toward muscle and bo...

Calculate 5-Amino-1MQ dose →
CagriSema
Metabolic & Mitochondrial

9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin slows gastric emptying and promotes satiety signaling....

Calculate CagriSema dose →
Key Parameters
Parameter 5-Amino-1MQ CagriSema
Category Metabolic & Mitochondrial Metabolic & Mitochondrial
Research Preclinical Phase III
Half-Life ~4 hours (estimated) -
Typical Dose 50 mg Cagrilintide 2.4 mg + Semaglutide 2.4 mg
Frequency Once daily Once weekly
Route Oral Subcutaneous (weekly)
FDA Status Not Approved Not Approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate 5-Amino-1MQ Calculate CagriSema
Frequently Asked Questions
What is the difference between 5-Amino-1MQ and CagriSema?
5-Amino-1MQ: 5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates NAD+ metabolism and energy expenditure in adipose tissue. By blocking NNMT, 5-Amino-1MQ r... CagriSema: 9%) and representing one of the strongest obesity pharmacotherapy results in clinical history. The combination works through complementary mechanisms: GLP-1 suppresses appetite centrally while amylin ...
Which has a longer half-life, 5-Amino-1MQ or CagriSema?
5-Amino-1MQ half-life: ~4 hours (estimated). CagriSema half-life: unknown.
Can you stack 5-Amino-1MQ and CagriSema?
5-Amino-1MQ and CagriSema are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.